Listen as Dr. Rosen shares how often non-Hodgkin lymphoma/NHL is a fatal diagnosis.
Non-Hodgkin’s lymphoma can be fatal. It isn’t fatal in every instance. They typically fall into three subsets, one called a high-grade, which if not treated can take an individual’s life over the course of weeks or months, but very high cure-rates with modern therapy.
The next group is referred to as intermediate grade; that group of non-Hodgkin’s lymphoma we can cure approximately half of the individuals, and the other half, unfortunately, succumb to the disease, and then the indolent non-Hodgkin’s lymphomas, which cannot be cured, but which we can control, in many instances, for decades.
About Dr. Steven Rosen, M.D., F.A.C.P:
Steven Rosen, M.D., F.A.C.P., is Genevieve Teuton Professor of Medicine, at the Feinberg School of Medicine, Northwestern University and Director of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University and Director of Cancer Programs at Northwestern Memorial Hospital. Following his graduation with distinction from Northwestern University Medical School's Six-Year Honors Program in 1976, Dr. Rosen completed his residency in Internal Medicine at Northwestern and a fellowship in Medical Oncology at the National Cancer Institute. Dr. Rosen's laboratory research focuses on experimental therapeutics and hematologic malignancies.